Skye Bioscience

Innovative Approach to Drug Development

San Diego, United States · Founded 2011 · $153.0M raised

Headquarters
San Diego
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$153.0M
Last Round
$40.0M Private EquityJan 2026
Rounds
5

About

Skye Bioscience (Nasdaq: SKYE) is a clinical-stage biotechnology company focused on modulating the endocannabinoid system to develop new treatments for obesity and comorbid metabolic conditions. Founded in 2011 and based in San Diego, California, the company's mission is to contribute new mechanisms and drugs that build the mosaic of therapeutic approaches needed to serve patients with diverse metabolic needs, led by President and CEO Punit Dhillon.

Summary

Skye Bioscience is a Biotech company based in San Diego, United States, founded in 2011. It has raised $153.0M in total across 5 rounds, most recently a $40.0M Private Equity round in Jan 2026. Investors include 5AM Ventures and Versant Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJan 2026
$40.0M

Sign up to see all 5 rounds

Seed through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Skye Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/skye-bioscience"><img src="https://indexed.vc/api/badge/company/skye-bioscience" alt="Skye Bioscience on Indexed.vc" width="260" height="76" /></a>